HomeServicesUnited KingdomTechnical Documentation
Back to UK Market Overview
UK MDR 2002 & UKCA Dossiers

UK MDR Technical Documentation & Gap Assessment

A registration record does not replace the technical evidence supporting the product. The manufacturer must maintain documentation demonstrating that the device meets the applicable regulatory requirements under the route being used to access Great Britain.

Tracing the Regulatory Story Across the Dossier

We do not review documents in isolation. We trace the complete regulatory narrative across every section of your technical file:

01

Intended Purpose

02

Classification

03

Risk Analysis

04

Requirements

05

V&V Testing

06

Clinical / PER Evidence

07

Labeling & IFU

08

PMS Feedback

18 Key Technical File Review Areas

Device description, variants, specifications and intended clinical purpose
Classification rationale against UK MDR 2002 Annex IX rules
Design and manufacturing process validation information
Essential Requirements / GSPR conformity evidence mapping
ISO 14971 risk management file and benefit-risk analysis
Clinical evaluation report (CER) or IVD performance evidence
Design verification and validation (V&V) data packages
ISO 10993 biocompatibility & chemical characterization
Sterilization validation and microbiological safety evidence
Packaging validation, transport simulation and shelf-life studies
IEC 60601-1 electrical safety and electromagnetic compatibility (EMC)
IEC 62304 software development lifecycle and verification
Cybersecurity documentation and vulnerability assessment
IEC 62366 usability engineering / human factors validation
Labeling, Instructions for Use (IFU) and UKCA / UKRP mark placement
Post-market surveillance (PMS) plan and PMSR / PSUR procedures
Vigilance, serious incident reporting and FSCA standard operating procedures
Change-control records and engineering change justifications

Gap Assessment Deliverables & Remediation Roadmap

1Critical regulatory nonconformity and compliance vulnerabilities
2Missing or insufficient technical and analytical testing evidence
3Internal document inconsistencies across engineering and regulatory files
4Outdated standards, harmonized references or obsolete test methods
5Weak traceability linkages between risk controls and test verification
6Clinical or IVD performance evidence sufficiency gaps
7Labeling, claims and Instructions for Use mismatches
8Post-market surveillance procedure and reporting gaps
9Prioritized, time-bound remediation roadmap for UKCA / Approved Body submission
Senior Regulatory Perspective

Coherent Evidence Over Presence of Documents

If the intended purpose, risk analysis, testing evidence and labeling describe different versions of the product or make unsupported claims, the file is not technically robust even if every document is present. We ensure complete cross-file consistency.

UKCA Conformity Routes

UK MDR 2002 Part II: Medical devices (Annex II, IV, V, VI routes)

UK MDR 2002 Part III: Active implantable medical devices

UK MDR 2002 Part IV: In vitro diagnostic medical devices

Audit Your Technical File

Have our regulatory engineers review your dossier against UK Approved Body expectations.

Schedule Technical Audit

Construct an Unassailable Technical File for UK Market Authorization

Our regulatory dossier specialists map Essential Requirements, clinical evidence, and risk management into a unified file.